Literature DB >> 17431187

Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.

Teresa Sanchez1, Athanasia Skoura, Ming Tao Wu, Brian Casserly, Elizabeth O Harrington, Timothy Hla.   

Abstract

OBJECTIVES: S1P acts via the S1PR family of G protein-coupled receptors to regulate a variety of physiological responses. Whereas S1P1R activates G(i)- and PI-3-kinase-dependent signals to inhibit vascular permeability, the related S1P2R inhibits the PI-3-kinase pathway by coupling to the Rho-dependent activation of the PTEN phosphatase. However, cellular consequences of S1P2R signaling in the vascular cells are not well understood. METHODS AND
RESULTS: Selective signaling of the S1P2R was achieved by adenoviral-mediated expression in endothelial cells. Secondly, endogenously expressed S1P2R was blocked by the specific pharmacological antagonist JTE013. Activation of S1P2R in endothelial cells resulted in Rho-ROCK- and PTEN-dependent disruption of adherens junctions, stimulation of stress fibers, and increased paracellular permeability. JTE013 treatment of naive endothelial cells potentiated the S1P1R-dependent effects such as formation of cortical actin, blockade of stress fibers, stimulation of adherens junction assembly, and improved barrier integrity. This observation was extended to the in vivo model of vascular permeability in the rat lung: the S1P2R antagonist JTE013 significantly inhibited H2O2-induced permeability in the rat lung perfused model.
CONCLUSIONS: S1P2R activation in endothelial cells increases vascular permeability. The balance of S1P1 and S1P2 receptors in the endothelium may determine the regulation of vascular permeability by S1P.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431187     DOI: 10.1161/ATVBAHA.107.143735

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  140 in total

1.  Differential modulation of S1PR(1-5) and specific activities of SphK and nSMase in pulmonary and cerebral tissues of rats exposed to hypobaric hypoxia.

Authors:  Sonam Chawla; Shweta Saxena
Journal:  Lipids       Date:  2014-11-16       Impact factor: 1.880

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules.

Authors:  Gengqian Zhang; Sulei Xu; Yan Qian; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

5.  Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma.

Authors:  Miriam B G Morrell; Claudia Alvarez-Florez; Aiqian Zhang; Eugenie S Kleinerman; Hannah Savage; Enrica Marmonti; Minjeong Park; Angela Shaw; Keri L Schadler
Journal:  Pediatr Blood Cancer       Date:  2019-05-28       Impact factor: 3.167

Review 6.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

7.  Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

Authors:  Athanasia Skoura; Teresa Sanchez; Kevin Claffey; Suzanne M Mandala; Richard L Proia; Timothy Hla
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Authors:  Lillian Cruz-Orengo; Brian P Daniels; Denise Dorsey; Sarah Alison Basak; José G Grajales-Reyes; Erin E McCandless; Laura Piccio; Robert E Schmidt; Anne H Cross; Seth D Crosby; Robyn S Klein
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

Review 9.  Sphingosine-1-phosphate receptor subtype 2 signaling in endothelial senescence-associated functional impairments and inflammation.

Authors:  Jiawei Zhao; Dante Garcia; Allison Gartung; Menq-Jer Lee
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

10.  Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.

Authors:  Pernille M Christensen; Catherine H Liu; Steven L Swendeman; Hideru Obinata; Klaus Qvortrup; Lars B Nielsen; Timothy Hla; Annarita Di Lorenzo; Christina Christoffersen
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.